Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment.

作者: J. David Peske , Amber B. Woods , Victor H. Engelhard

DOI: 10.1016/BS.ACR.2015.05.001

关键词:

摘要: CD8 T-cells are a critical brake on the initial development of tumors. In established tumors, presence is correlated with positive patient prognosis, although immunosuppressive mechanisms limit their effectiveness and they rarely curative without manipulation. Cancer immunotherapies aim to shift balance back dominant antitumor immunity through antibody blockade signaling pathways, vaccination, adoptive transfer activated or engineered T-cells. These approaches have yielded striking responses in small subsets patients solid most notably those melanoma. Importantly, subset who respond vaccination immunosuppression therapies present tumor prior initiating therapy. While current cell therapy can be dramatically effective, require infusion extremely large numbers T-cells, but number that actually infiltrates very small. Thus, poor representation tumors fundamental hurdle successful immunotherapy, over above well-established barrier immunosuppression. this review, we discuss factors determine whether immune cells focus cytotoxic We emphasize critically important role tumor-associated vasculature as gateway enables active infiltration both effector naive exert activity. also strategies enhance function extend broader set cancer patients.

参考文章(258)
Lucio Palma, Nicola Di Lorenzo, Beniamino Guidetti, Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases. Journal of Neurosurgery. ,vol. 49, pp. 854- 861 ,(1978) , 10.3171/JNS.1978.49.6.0854
S. Goelz, R. Kumar, B. Potvin, S. Sundaram, M. Brickelmaier, P. Stanley, Differential expression of an E-selectin ligand (SLex) by two Chinese hamster ovary cell lines transfected with the same alpha (1,3)-fucosyltransferase gene (ELFT). Journal of Biological Chemistry. ,vol. 269, pp. 1033- 1040 ,(1994) , 10.1016/S0021-9258(17)42216-2
Natalio Garbi, Bernd Arnold, Siamon Gordon, Günter J. Hämmerling, Ruth Ganss, CpG Motifs as Proinflammatory Factors Render Autochthonous Tumors Permissive for Infiltration and Destruction The Journal of Immunology. ,vol. 172, pp. 5861- 5869 ,(2004) , 10.4049/JIMMUNOL.172.10.5861
Longbiao Yao, Hendra Setiadi, Lijun Xia, Zoltan Laszik, Fletcher B. Taylor, Rodger P. McEver, Divergent Inducible Expression of P-Selectin and E-Selectin in Mice and Primates Blood. ,vol. 94, pp. 3820- 3828 ,(1999) , 10.1182/BLOOD.V94.11.3820
C A Dinarello, M Fabrigoule, G Kaplanski, S Kaplanski, V Boulay, P Bongrand, C Farnarier, Thrombin induces endothelial type II activation in vitro: IL-1 and TNF-alpha-independent IL-8 secretion and E-selectin expression. Journal of Immunology. ,vol. 158, pp. 5435- 5441 ,(1997)
Vijay Shankaran, Hiroaki Ikeda, Allen T. Bruce, J. Michael White, Paul E. Swanson, Lloyd J. Old, Robert D. Schreiber, IFNγ, and lymphocytes prevent primary tumour development and shape tumour immunogenicity Nature. ,vol. 410, pp. 1107- 1111 ,(2001) , 10.1038/35074122
Terry G. Coursey, Ritu Bohat, Flavia L. Barbosa, Stephen C. Pflugfelder, Cintia S. de Paiva, Desiccating Stress–Induced Chemokine Expression in the Epithelium Is Dependent on Upregulation of NKG2D/RAE-1 and Release of IFN-γ in Experimental Dry Eye Journal of Immunology. ,vol. 193, pp. 5264- 5272 ,(2014) , 10.4049/JIMMUNOL.1400016
Shu-Cheng Chen, Galya Vassileva, David Kinsley, Sandra Holzmann, Denise Manfra, Maria T. Wiekowski, Nikolaus Romani, Sergio A. Lira, Ectopic Expression of the Murine Chemokines CCL21a and CCL21b Induces the Formation of Lymph Node-Like Structures in Pancreas, But Not Skin, of Transgenic Mice Journal of Immunology. ,vol. 168, pp. 1001- 1008 ,(2002) , 10.4049/JIMMUNOL.168.3.1001
Sherven Sharma, Marina Stolina, Jie Luo, Robert M. Strieter, Marie Burdick, Li X. Zhu, Raj K. Batra, Steven M. Dubinett, Secondary Lymphoid Tissue Chemokine Mediates T Cell-Dependent Antitumor Responses In Vivo Journal of Immunology. ,vol. 164, pp. 4558- 4563 ,(2000) , 10.4049/JIMMUNOL.164.9.4558